Regulus Therapeutics reported $146K in Ordinary Share Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Astrazeneca AZN:US $ 387M 0M
AstraZeneca AZN:LN 387M 0M
Biogen BIIB:US $ 0.1M 0M
Celldex Therapeutics CLDX:US $ 0.05M 0M
Gilead Sciences GILD:US $ 1M 0M
GlaxoSmithKline GSK:LN 1347M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
Intrexon XON:US $ 0M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Lexicon Pharmaceuticals LXRX:US $ 0.15M 0M
Ligand Pharmaceuticals LGND:US $ 0.02M 0M
Merk MRK:US $ 1788M 0M
Omeros OMER:US $ 627K 1000
Regulus Therapeutics RGLS:US $ 0.15M 0M
Sangamo Biosciences SGMO:US $ 1.47M 0.01M
Spectrum Pharmaceuticals SPPI:US $ 0.18M 0.01M
Takeda 4502:JP Y 1676263M 0M
Vital Therapies VTL:US $ 0M 0M
YTE INCY:US $ 0.22M 0M